Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Global Healthcare ETF (NY:IXJ)

96.48 -0.01 (-0.01%)
Streaming Delayed Price Updated: 11:14 AM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Global Healthcare ETF

News headline image
Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul ↗
Via MarketBeat
Trump Steps Up Pressure On Trading Partners Over Drug Costs, Plans Section 301 Review: Report ↗
Via Stocktwits
Topics Government
Trump Walks Back Plan To Slap Tariffs On Generic Drugs After White House Clash Over Prices, Supply Risks: Report ↗
Via Stocktwits
Topics Government
News headline image
Trump Admin Targets Medicaid Spending On Immigrants, Threatening Over $12 Billion California Program ↗
The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse in immigrant healthcare programs. 
Via Benzinga
Topics Government
News headline image
Trump Pollster Quietly Tells Republicans: Voters Still Trust Childhood Vaccines, Doubt COVID Shots ↗
The Fabrizio Ward survey of 1,000 voters found 77% of Trump supporters back measles shots and 69% support hepatitis B, while at least 90% of Kamala Harris voters backed all three vaccines. 
Via Stocktwits
Topics ETFs Government
CDC In Crisis: Kennedy Pressured To Quit As States Revolt Over Vaccine Board Shake-Up ↗
Via Stocktwits
Trump’s Big Pharma Tariff Call Delayed Again As White House Juggles Trade Battles And Diplomatic Showdowns: Report ↗
Via Stocktwits
Topics Government
Trump Plans Gradual Tariff Hike On Imported Pharma To 250% Over 18 Months To Boost US Production ↗
Via Stocktwits
Topics Government
RFK Jr. Said To Be Planning Another Health Panel Shakeup — This Time Targeting Preventive Care ↗
Via Stocktwits
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca ↗
Via Stocktwits
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗
Via Stocktwits
Topics Government
News headline image
Trump Overrode RFK Jr. And Makary To Remove FDA Biologics Chief Amid Sarepta Drug Controversy: Report ↗
The Trump administration is reportedly considering a major restructuring of the FDA’s biologics division, potentially splitting it into separate offices for vaccines and therapeutics. 
Via Stocktwits
Topics Death ETFs Government
News headline image
Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)
In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at... 
Via MarketMinute
Topics ETFs Economy
News headline image
Global Healthcare ETFs ↗
Trevor Cummings discusses Global Healthcare ETFs and outlook for the rest of 2021 with Deborah Fuhr. 
Via Talk Markets
News headline image
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH. 
Via Benzinga
News headline image
AbbVie Stock Nears 3-Month High on Q4 Beat As Immunology Growth Eases Humira Slump: Retail Mood Brightens ↗
The company raised its long-term sales outlook for Skyrizi and Rinvoq, now expecting combined revenue of about $24 billion in 2025. 
Via Stocktwits
News headline image
J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient ↗
During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually. 
Via Stocktwits
Topics Earnings
News headline image
World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements ↗
Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate. 
Via Benzinga
Topics Government
News headline image
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy ↗
You don't need to be a stock market expert to earn above-average returns. 
Via The Motley Fool
News headline image
Top ETFs for Every Sector ↗
Top ETFs for all 11 S&P 500 sectors. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Market Mayhem: 3 ETFs to Anchor Your Investments in 2024 ↗
The top ETFs for 2024 are thematic or sector-specific tickers with upside, presenting market-beating opportunities. 
Via InvestorPlace
Topics ETFs
News headline image
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.  
Via Benzinga
News headline image
3 Healthcare Technology Stocks to Improve Lives in 2024 ↗
Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks. 
Via InvestorPlace
News headline image
Worried About a Recession? Stash Your Cash in These 2 ETFs. ↗
Rather than holding your cash, consider investing it in these stable ETFs. 
Via The Motley Fool
News headline image
US Supports Delay On COVID Patent Waiver Extension Decision ↗
Developing countries have been pushing for a patent waiver extension for COVID-19, which many developed countries argue could discourage pharma companies from responding rapidly to future global health... 
Via Benzinga
News headline image
7 Profitable Places to Hide Your Money During a Bear Market ↗
With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification. 
Via InvestorPlace
News headline image
Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19 ↗
The World Health Organization said that it's not recommending the use of convalescent plasma as a treatment for COVID-19 for mild or severe cases. The treatment uses... 
Via Benzinga
News headline image
New Drug Applications Pile Up With FDA As Pandemic Still Sore Spot For Delayed Inspections ↗
The FDA continues to face a backlog of drug manufacturing facility inspections. A total of 52 new drug (but no biologics) applications remain delayed due to the backlog... 
Via Benzinga
News headline image
UK Rolls Out COVID-19 Antibody Tests For All: What You Need To Know ↗
On Sunday, the U.K. government rolled out a new nationwide antibody surveillance program, in which anyone over 18 years can opt-in when having a PCR test from Tuesday.... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.